Medical Care
Global Psoriatic Arthritis (PsA) Treatment Market Research Report 2025
- Sep 18, 25
- ID: 507774
- Pages: 87
- Figures: 88
- Views: 25
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis (PsA) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis (PsA) Treatment.
The Psoriatic Arthritis (PsA) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriatic Arthritis (PsA) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis (PsA) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
AbbVie
Novartis
UCB
Roche
Bristol-Myers Squibb
Eli Lilly
Amgen
AstraZeneca
Celgene
Segment by Type
Nonsteriodal Anti-inflammatory Drugs
Disease Modifying Antirheumatic Drugs
Biologics
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis (PsA) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Psoriatic Arthritis (PsA) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriatic Arthritis (PsA) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis (PsA) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
AbbVie
Novartis
UCB
Roche
Bristol-Myers Squibb
Eli Lilly
Amgen
AstraZeneca
Celgene
Segment by Type
Nonsteriodal Anti-inflammatory Drugs
Disease Modifying Antirheumatic Drugs
Biologics
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis (PsA) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nonsteriodal Anti-inflammatory Drugs
1.2.3 Disease Modifying Antirheumatic Drugs
1.2.4 Biologics
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriatic Arthritis (PsA) Treatment Market Perspective (2020-2031)
2.2 Global Psoriatic Arthritis (PsA) Treatment Growth Trends by Region
2.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Psoriatic Arthritis (PsA) Treatment Historic Market Size by Region (2020-2025)
2.2.3 Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2026-2031)
2.3 Psoriatic Arthritis (PsA) Treatment Market Dynamics
2.3.1 Psoriatic Arthritis (PsA) Treatment Industry Trends
2.3.2 Psoriatic Arthritis (PsA) Treatment Market Drivers
2.3.3 Psoriatic Arthritis (PsA) Treatment Market Challenges
2.3.4 Psoriatic Arthritis (PsA) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue
3.1.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue (2020-2025)
3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Psoriatic Arthritis (PsA) Treatment Revenue
3.4 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis (PsA) Treatment Revenue in 2024
3.5 Global Key Players of Psoriatic Arthritis (PsA) Treatment Head office and Area Served
3.6 Global Key Players of Psoriatic Arthritis (PsA) Treatment, Product and Application
3.7 Global Key Players of Psoriatic Arthritis (PsA) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Type
4.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Type (2020-2025)
4.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2026-2031)
5 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Application
5.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Application (2020-2025)
5.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
6.2 North America Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
6.4 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
7.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
8.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
9.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
9.4 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
10.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Introduction
11.1.4 Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Introduction
11.3.4 AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.3.5 AbbVie Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Introduction
11.4.4 Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 UCB
11.5.1 UCB Company Details
11.5.2 UCB Business Overview
11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Introduction
11.5.4 UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.5.5 UCB Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Introduction
11.6.4 Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Introduction
11.7.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Introduction
11.8.4 Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.8.5 Eli Lilly Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Introduction
11.9.4 Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.9.5 Amgen Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Introduction
11.10.4 AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.10.5 AstraZeneca Recent Development
11.11 Celgene
11.11.1 Celgene Company Details
11.11.2 Celgene Business Overview
11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Introduction
11.11.4 Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.11.5 Celgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nonsteriodal Anti-inflammatory Drugs
1.2.3 Disease Modifying Antirheumatic Drugs
1.2.4 Biologics
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriatic Arthritis (PsA) Treatment Market Perspective (2020-2031)
2.2 Global Psoriatic Arthritis (PsA) Treatment Growth Trends by Region
2.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Psoriatic Arthritis (PsA) Treatment Historic Market Size by Region (2020-2025)
2.2.3 Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2026-2031)
2.3 Psoriatic Arthritis (PsA) Treatment Market Dynamics
2.3.1 Psoriatic Arthritis (PsA) Treatment Industry Trends
2.3.2 Psoriatic Arthritis (PsA) Treatment Market Drivers
2.3.3 Psoriatic Arthritis (PsA) Treatment Market Challenges
2.3.4 Psoriatic Arthritis (PsA) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue
3.1.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue (2020-2025)
3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Psoriatic Arthritis (PsA) Treatment Revenue
3.4 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis (PsA) Treatment Revenue in 2024
3.5 Global Key Players of Psoriatic Arthritis (PsA) Treatment Head office and Area Served
3.6 Global Key Players of Psoriatic Arthritis (PsA) Treatment, Product and Application
3.7 Global Key Players of Psoriatic Arthritis (PsA) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Type
4.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Type (2020-2025)
4.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2026-2031)
5 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Application
5.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Application (2020-2025)
5.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
6.2 North America Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
6.4 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
7.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
8.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
9.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
9.4 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
10.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Introduction
11.1.4 Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Introduction
11.3.4 AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.3.5 AbbVie Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Introduction
11.4.4 Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 UCB
11.5.1 UCB Company Details
11.5.2 UCB Business Overview
11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Introduction
11.5.4 UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.5.5 UCB Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Introduction
11.6.4 Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Introduction
11.7.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Introduction
11.8.4 Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.8.5 Eli Lilly Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Introduction
11.9.4 Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.9.5 Amgen Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Introduction
11.10.4 AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.10.5 AstraZeneca Recent Development
11.11 Celgene
11.11.1 Celgene Company Details
11.11.2 Celgene Business Overview
11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Introduction
11.11.4 Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
11.11.5 Celgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nonsteriodal Anti-inflammatory Drugs
Table 3. Key Players of Disease Modifying Antirheumatic Drugs
Table 4. Key Players of Biologics
Table 5. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region (2020-2025)
Table 9. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region (2026-2031)
Table 11. Psoriatic Arthritis (PsA) Treatment Market Trends
Table 12. Psoriatic Arthritis (PsA) Treatment Market Drivers
Table 13. Psoriatic Arthritis (PsA) Treatment Market Challenges
Table 14. Psoriatic Arthritis (PsA) Treatment Market Restraints
Table 15. Global Psoriatic Arthritis (PsA) Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players (2020-2025)
Table 17. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2024)
Table 18. Ranking of Global Top Psoriatic Arthritis (PsA) Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Psoriatic Arthritis (PsA) Treatment, Headquarters and Area Served
Table 21. Global Key Players of Psoriatic Arthritis (PsA) Treatment, Product and Application
Table 22. Global Key Players of Psoriatic Arthritis (PsA) Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Psoriatic Arthritis (PsA) Treatment Product
Table 50. Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Johnson & Johnson Company Details
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product
Table 55. Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. AbbVie Company Details
Table 58. AbbVie Business Overview
Table 59. AbbVie Psoriatic Arthritis (PsA) Treatment Product
Table 60. AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 61. AbbVie Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Psoriatic Arthritis (PsA) Treatment Product
Table 65. Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. UCB Company Details
Table 68. UCB Business Overview
Table 69. UCB Psoriatic Arthritis (PsA) Treatment Product
Table 70. UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 71. UCB Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Psoriatic Arthritis (PsA) Treatment Product
Table 75. Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Bristol-Myers Squibb Company Details
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product
Table 80. Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Eli Lilly Company Details
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product
Table 85. Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 86. Eli Lilly Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Psoriatic Arthritis (PsA) Treatment Product
Table 90. Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product
Table 95. AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 96. AstraZeneca Recent Development
Table 97. Celgene Company Details
Table 98. Celgene Business Overview
Table 99. Celgene Psoriatic Arthritis (PsA) Treatment Product
Table 100. Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 101. Celgene Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Psoriatic Arthritis (PsA) Treatment Picture
Figure 2. Global Psoriatic Arthritis (PsA) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Psoriatic Arthritis (PsA) Treatment Market Share by Type: 2024 VS 2031
Figure 4. Nonsteriodal Anti-inflammatory Drugs Features
Figure 5. Disease Modifying Antirheumatic Drugs Features
Figure 6. Biologics Features
Figure 7. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Psoriatic Arthritis (PsA) Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Psoriatic Arthritis (PsA) Treatment Report Years Considered
Figure 13. Global Psoriatic Arthritis (PsA) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Psoriatic Arthritis (PsA) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players in 2024
Figure 17. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue in 2024
Figure 19. North America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)
Figure 21. United States Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)
Figure 25. Germany Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Share by Region (2020-2031)
Figure 33. China Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 49. Johnson & Johnson Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 50. AbbVie Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 52. UCB Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 53. Roche Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 55. Eli Lilly Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 56. Amgen Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 57. AstraZeneca Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 58. Celgene Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nonsteriodal Anti-inflammatory Drugs
Table 3. Key Players of Disease Modifying Antirheumatic Drugs
Table 4. Key Players of Biologics
Table 5. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region (2020-2025)
Table 9. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region (2026-2031)
Table 11. Psoriatic Arthritis (PsA) Treatment Market Trends
Table 12. Psoriatic Arthritis (PsA) Treatment Market Drivers
Table 13. Psoriatic Arthritis (PsA) Treatment Market Challenges
Table 14. Psoriatic Arthritis (PsA) Treatment Market Restraints
Table 15. Global Psoriatic Arthritis (PsA) Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players (2020-2025)
Table 17. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2024)
Table 18. Ranking of Global Top Psoriatic Arthritis (PsA) Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Psoriatic Arthritis (PsA) Treatment, Headquarters and Area Served
Table 21. Global Key Players of Psoriatic Arthritis (PsA) Treatment, Product and Application
Table 22. Global Key Players of Psoriatic Arthritis (PsA) Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Psoriatic Arthritis (PsA) Treatment Product
Table 50. Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Johnson & Johnson Company Details
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product
Table 55. Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. AbbVie Company Details
Table 58. AbbVie Business Overview
Table 59. AbbVie Psoriatic Arthritis (PsA) Treatment Product
Table 60. AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 61. AbbVie Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Psoriatic Arthritis (PsA) Treatment Product
Table 65. Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. UCB Company Details
Table 68. UCB Business Overview
Table 69. UCB Psoriatic Arthritis (PsA) Treatment Product
Table 70. UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 71. UCB Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Psoriatic Arthritis (PsA) Treatment Product
Table 75. Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Bristol-Myers Squibb Company Details
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product
Table 80. Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Eli Lilly Company Details
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product
Table 85. Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 86. Eli Lilly Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Psoriatic Arthritis (PsA) Treatment Product
Table 90. Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product
Table 95. AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 96. AstraZeneca Recent Development
Table 97. Celgene Company Details
Table 98. Celgene Business Overview
Table 99. Celgene Psoriatic Arthritis (PsA) Treatment Product
Table 100. Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)
Table 101. Celgene Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Psoriatic Arthritis (PsA) Treatment Picture
Figure 2. Global Psoriatic Arthritis (PsA) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Psoriatic Arthritis (PsA) Treatment Market Share by Type: 2024 VS 2031
Figure 4. Nonsteriodal Anti-inflammatory Drugs Features
Figure 5. Disease Modifying Antirheumatic Drugs Features
Figure 6. Biologics Features
Figure 7. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Psoriatic Arthritis (PsA) Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Psoriatic Arthritis (PsA) Treatment Report Years Considered
Figure 13. Global Psoriatic Arthritis (PsA) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Psoriatic Arthritis (PsA) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players in 2024
Figure 17. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue in 2024
Figure 19. North America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)
Figure 21. United States Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)
Figure 25. Germany Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Share by Region (2020-2031)
Figure 33. China Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 49. Johnson & Johnson Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 50. AbbVie Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 52. UCB Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 53. Roche Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 55. Eli Lilly Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 56. Amgen Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 57. AstraZeneca Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 58. Celgene Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232